Hematopoietic and Lymphoid System Neoplasm Withdrawn Phase 2 Trials for Tacrolimus (DB00864)

IndicationStatusPhase
DBCOND0132171 (Hematopoietic and Lymphoid System Neoplasm)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03602898Comparing ATG or Post-Transplant Cyclophosphamide to Calcineurin Inhibitor-Methotrexate as GVHD Prophylaxis After Myeloablative Unrelated Donor Peripheral Blood Stem Cell TransplantationTreatment